BCX7353, a once-daily oral kallikrein inhibitor, is effective and safe in the prophylaxis of acute attacks in patients with hereditary angioedema: Attack-level analysis of the APeX-1 study
| Autor: | Aygören, E., Bygum, A., Steiner, U., Magerl, M., Panovska, V.G., Farkas, H., Huissoon, A., Graff, J., Lleonart, R., Rae, W., Aberer, W., Longhurst, H., Smith, W., Zanichelli, A., Cancian, M., Guilarte, M., Triggiani, M., Gompels, M., Fang, L., Cornpropst, M., Clemons, D., Collis, P., Dobo, S., Sheridan, W.P., Maurer, M., Cicardi, M. |
|---|---|
| Přispěvatelé: | Publica |
| Jazyk: | angličtina |
| Rok vydání: | 2017 |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|